The Sepsis Diagnostics Market Revenue was valued at USD 1.2 billion in 2023 and is projected to surge to USD 2.5 billion by 2032, registering a robust CAGR of 8.6% during the forecast period 2024–2032. This growth is fueled by the increasing global prevalence of sepsis, advancements in diagnostic technologies, and heightened healthcare awareness.Key Growth DriversSepsis, a life-threatening medic..